查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495989

健康老化（心血管和骨骼健康食品和饮料）市场：2024-2029 年预测

Cardiovascular and Bone Health Positioned Food and Beverages (Healthy Aging Market) - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

健康老化（心血管和骨骼健康食品和饮料）市场在预测期内将以11.07%的年复合成长率增长，从2022年的407.92亿美元增长到2029年的949.45亿美元。 。

心血管和骨骼健康领域的健康老化食品和饮料是旨在随着老龄化支持心血管健康、骨骼健康和整体福祉的产品。这些产品含有有益心臟健康的营养素，如Omega-3脂肪酸、抗氧化剂、膳食纤维和植物固醇，有助于维持健康的胆固醇水平并降低心血管疾病的风险。它还含有对骨骼矿化和密度起重要作用的营养素，如钙、维生素 D、维生素 K 和镁。

健康老龄化需要采取整体方法，包括保持身体健康、促进营养平衡、支持免疫系统以及应对与老龄化相关的健康挑战。多年来，生活方式的改变迫使我们采取健康的生活方式。人们对自身健康和福祉的意识日益增强，为健康老化市场的开拓创造了巨大的机会。

世界人口正在迅速老化。这增加了采用具有促进健康老化特效的食品和补充品的需求。除此之外，对心血管疾病、维生素缺乏导致骨痛以及健康问题的日益关注也是健康老化市场的主要驱动力。市场的主要限制因素之一是普及在连生活必需品都缺乏的欠发达地区。

市场驱动因素

  • 心血管疾病的增加将推动市场成长

不健康的饮食、缺乏运动、大量吸烟、吸烟改变的生活方式、都市化和污染是多年来影响我们健康和福祉的一些因素，导致心血管疾病的发病率逐年增加做出了贡献据世界卫生组织称，每年约有 1790 万人死于心血管疾病，使 CVD 成为全球主要死亡原因。 CVD（心血管疾病）包括多种与心臟相关的疾病，如脑血管疾病、冠状动脉心臟病和风湿性心臟病，久而久之会导致中风和心臟病发作。

据世界卫生组织称，五分之四的心血管疾病死亡是由于心臟病和中风造成的，这使其成为一个严重问题。此外，研究表明，随着老龄化，免疫力会减弱，身体也会衰弱，增加心血管疾病的威胁。根据联合国提供的资料，65岁以上人口比例从1990年的6%上升到2019年的9%。 2019年，全球65岁以上人口有7.03亿，预计到2050年将翻倍，达到15亿人。根据这些预测，心血管疾病病例预计将进一步增加，并强调健康老化的必要性。

识字率的提高、意识提升宣传活动和政府措施极大地促进了人们透过吃健康食品来采取健康的生活方式。这就是为什么心血管健康产品和补充品，如草药产品、植物固醇产品、Coenzyme Q10或 CoQ10补充品、低脂乳製品、全谷谷物和坚果、鱼油和Omega-3脂肪酸补充品正在帮助人们。一部分，并为引导健康生活提供了巨大的机会。

  • 骨骼相关疾病的增加预计将推动市场成长。

除了心血管疾病外，扰乱健康老化食品和饮料市场的关键机会之一是占领骨骼相关疾病高发生率地区。钙缺乏、维生素D缺乏、人口老化、体重过低、吸烟、过量摄取、缺乏运动等是骨质疏鬆、石骨症等议题的重要领域。

骨质疏鬆症是最常见的骨骼疾病，它会削弱骨骼结构和组织，使其强度降低，更容易骨折。美国疾病管制与预防中心的研究显示，50岁及以上成年人的骨质疏鬆症年龄调整盛行率从2007-2008年的9.4%上升到2017-2018年的12.6%。由于出生率下降，人口老化不断增加，这为骨骼相关的健康老化市场创造了机会。

市场限制因素

  • 与补充品相关的监管和安全可能会阻碍市场

市场成长的主要限制因素之一是补充品和其他健康产品的安全性。这是因为许多补充品尚未对孕妇和儿童进行初步测试，这可能会阻碍市场成长。此外，FDA 关于补充品的法规也可能对市场构成威胁。产品上市后，FDA 会根据消费者评论追踪其副作用。如果发现产品不安全，FDA 可以对製造商采取严格的法律行动或发出警告，将产品撤出市场。

主要进展：

  • 2023 年 11 月 -BASF股份公司是一家生产、行销和销售化学品、塑胶、农作物保护产品和高性能产品的化学公司。我们为各行业提供服务，并与全球客户、科学家和合作伙伴合作进行研发。BASF服务欧洲有限公司在柏林开设了一个占地 15,000 平方米的新服务中心，共有 8平方公尺。该公司为BASF集团在欧洲、中东和非洲的公司提供业务管理服务。
  • 2022 年 8 月 - ADM 和 Benson Hill 宣布建立策略合作伙伴关係，以扩大植物蛋白的创新大豆成分。 ADM 对源自 Benson Hill 超高蛋白大豆的专有原料进行加工和商业化，以提供加工较少的蛋白质，同时考虑到水和碳的永续性。此次合作将 ADM 的来源、应用和配方专业知识与 Benson Hill 的 CropOS 技术平台相结合，为高价值替代蛋白质产品的商业规模生产开闢了道路。这种伙伴关係将我们的农民伙伴带入了从种子到餐桌的食品革命。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章心血管和骨骼健康食品和饮料：健康老化市场：按产品类型（心血管健康）

  • 介绍
  • 植物固醇类产品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 全谷谷物和坚果
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 鱼油和Omega-3脂肪酸补充品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • Coenzyme Q10或 CoQ10补充品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 低脂乳製品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 草药处方
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章心血管和骨骼健康食品和饮料：健康老化市场：按产品类型（骨骼健康）

  • 介绍
  • 补充品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 维生素 D补充品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 镁补充品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 补充品维生素K2
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章心血管和骨骼健康食品和饮料：健康老化市场：按分销管道

  • 介绍
  • 在线的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 离线
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章心血管和骨骼健康食品和饮料：健康老化市场：按地区

  • 介绍
  • 北美洲
    • 按产品类型（心血管健康）
    • 依产品类型（骨骼健康）
    • 按分销管道
    • 按国家/地区
  • 南美洲
    • 按产品类型（心血管健康）
    • 依产品类型（骨骼健康）
    • 按分销管道
    • 按国家/地区
  • 欧洲
    • 按产品类型（心血管健康）
    • 依产品类型（骨骼健康）
    • 按分销管道
    • 按国家/地区
  • 中东/非洲
    • 按产品类型（心血管健康）
    • 依产品类型（骨骼健康）
    • 按分销管道
    • 按国家/地区
  • 亚太地区
    • 按产品类型（心血管健康）
    • 依产品类型（骨骼健康）
    • 按分销管道
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Now Health Group Inc.
  • Herbal Hills
  • Nature's Way Products, LLC
  • Cosmic Nutracos Solutions Private Limited
  • Nestle Health Science SA
  • Nordic Naturals
  • Abbott Laboratories
  • Ion Labs
  • Amway
  • GNC Holdings Inc.
简介目录
Product Code: KSI061611709

The cardiovascular and bone health positioned food and beverages: the healthy aging market is expected to grow at a compound annual growth rate of 11.07% over the forecast period to reach a market size of US$94.945 billion in 2029, from US$40.792 billion in 2022.

Cardiovascular and bone health-positioned food and beverages for healthy aging are products designed to support cardiovascular health, bone health, and overall well-being in the context of aging. These products include heart-friendly nutrients like omega-3 fatty acids, antioxidants, fiber, and plant sterols, which help maintain healthy cholesterol levels and reduce the risk of cardiovascular diseases. They also contain nutrients like calcium, vitamin D, vitamin K, and magnesium, which play a crucial role in bone mineralization and density.

Healthy aging encompasses a holistic approach to maintaining well-being, promoting overall nutritional balance, supporting the immune system, and managing age-related health challenges. Over the years, changing living patterns have driven us towards the need to adopt a healthy lifestyle. People are becoming more conscious about their health and well-being, which has opened up a great opportunity to develop the healthy aging market.

The global population is aging at a fast rate. This has increased the need to adopt food and wellness products and supplements that carry the extra benefits of promoting healthy aging. Apart from that, the rising concerns relating to cardiovascular diseases, vitamin deficiencies leading to bone pains, and health issues are also major driving factors for the healthy aging market. One of the major restraints for the market is to expand its reach in less developed regions that lack even the necessities of life.

Market Drivers

  • The rise of cardiovascular diseases will bolster the market growth

Changing living patterns accompanied by an unhealthy diet, lack of physical activity, high consumption of tobacco, smoking, urbanization, and pollution are some of the elements playing with our health and wellness for years and have contributed to the rise of cardiovascular diseases over the years. According to WHO, around 17.9 million die from cardiovascular diseases every year, which has made CVDs a leading cause of death globally. CVDs or Cardio Vascular Diseases include a range of heart-related disorders like cerebrovascular disease, coronary heart disease, rheumatic heart disease, etc. that can give rise to chances of strokes and heart attacks with time.

WHO says that around four out of five CVD deaths are due to heart attacks and stroke, becoming major concerns. Besides that, studies have found that with aging, the threat of cardiovascular diseases increases due to low immunity and a weak body, as well as the threat of other diseases. According to the data provided by the UN, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019. There were 703 million persons aged 65 years or over in the world in 2019, which is expected to double to 1.5 billion in 2050. With these projections, the cases of cardiovascular diseases are projected to increase further, which calls for the need for healthy aging.

The growing literacy, the rising awareness campaigns, and government initiatives contribute significantly to making people adopt a healthy lifestyle by eating a healthy diet. This, therefore, has opened up a significant opportunity for cardiovascular-related wellness products and supplements like herbal products, phytosterol-based commodities, coenzyme Q10 or CoQ10 supplements, low-fat dairy products, whole grains and nuts, fish oil, and omega 3 fatty acid supplements to become a part of people's diet and induce healthy living in them.

  • Increasing bone-related diseases are anticipated to surge the market growth.

Apart from cardiovascular diseases, one of the major opportunities for developing the healthy aging food and beverages market is to acquire the areas of high bone-related diseases. Calcium deficiency, vitamin D deficiency, population aging, low body weight, smoking, excess alcohol consumption, physical inactivity, etc., are critical areas that suffer from problems like osteoporosis and osteopetrosis, etc.

Osteoporosis is the most common bone disease that weakens the bone structure and tissue, due to which bone loses strength, which increases the chances of fractures. According to a survey conducted by the Centers for Disease Control and Prevention in the USA, the age-adjusted prevalence of osteoporosis among adults aged 50 and over increased from 9.4% in 2007-2008 to 12.6% in 2017-2018. With the declining birth rate, the aged population is rising, which has created an opportunity for the bone-related healthy aging market.

Market Restraints

  • Regulations and safety associated with the supplements could hinder the market

One of the major restraints for the market growth is the safety associated with supplements and other wellness products. This is because many of these supplements do not go through any prior testing for pregnant women and children, and this can hamper the market growth. Besides that, the regulation by the FDA on the supplements can pose another threat to the market. Once the product is marketed, the FDA tracks its side effects as per consumer reviews. If the product is found unsafe, the FDA can take strict legal actions against the manufacturer or issue a warning to remove the product from the market.

Key Developments:

  • November 2023- BASF SE, a chemical company that produces, markets, and sells chemicals, plastics, crop protection products, and performance products. It serves various industries and conducts R&D in alliance with global customers, scientists, and partners. BASF Services Europe GmbH opened a new service hub in Berlin, using 15,000 square meters over eight floors. The company provides business management services for BASF Group companies in Europe, the Middle East, and Africa.
  • August 2022- ADM and Benson Hill announced a strategic partnership to scale innovative soy ingredients for plant-based proteins. ADM will process and commercialize proprietary ingredients derived from Benson Hill Ultra-High Protein soybeans, offering less-processed proteins with water and carbon sustainability benefits. The partnership is going to create a pathway towards commercial-scale seed-to-fork production of higher-value alternative protein products, combining ADM's expertise in origination, applications, and formulation with Benson Hill's CropOS technology platform. The collaboration engages farmer partners in the seed-to-fork food revolution.

Segmentation:

By Product Type (Cardiovascular Health)

  • Phytosterol-based commodities
  • Whole grains and nuts
  • Fish oil and omega-3 fatty acid supplements
  • Coenzyme Q10 or CoQ10 supplements
  • Low-fat dairy products
  • Herbal formulas
  • Others

By Product Type (Bone Health)

  • Calcium supplements
  • Vitamin D supplements
  • Magnesium supplements
  • Vitamin K2 supplements
  • Others

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • U.K.
  • Germany
  • France
  • Others
  • Middle East and Africa
  • UAE
  • South Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Taiwan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY PRODUCT TYPE (CARDIOVASCULAR HEALTH)

  • 5.1. Introduction
  • 5.2. Phytosterol-based commodities
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Whole grains and nuts
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Fish oil and omega-3 fatty acid supplements
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Coenzyme Q10 or CoQ10 supplements
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Low-fat dairy products
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness
  • 5.7. Herbal formulas
    • 5.7.1. Market Opportunities and Trends
    • 5.7.2. Growth Prospects
    • 5.7.3. Geographic Lucrativeness
  • 5.8. Others
    • 5.8.1. Market Opportunities and Trends
    • 5.8.2. Growth Prospects
    • 5.8.3. Geographic Lucrativeness

6. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY PRODUCT TYPE (BONE HEALTH)

  • 6.1. Introduction
  • 6.2. Calcium supplements
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Vitamin D supplements
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Magnesium supplements
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Vitamin K2 supplements
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness
  • 6.6. Others
    • 6.6.1. Market Opportunities and Trends
    • 6.6.2. Growth Prospects
    • 6.6.3. Geographic Lucrativeness

7. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Offline
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type (Cardiovascular Health)
    • 8.2.2. By Product Type (Bone Health)
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product Type (Cardiovascular Health)
    • 8.3.2. By Product Type (Bone Health)
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product Type (Cardiovascular Health)
    • 8.4.2. By Product Type (Bone Health)
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. U.K.
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type (Cardiovascular Health)
    • 8.5.2. By Product Type (Bone Health)
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. UAE
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. South Africa
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Saudi Arabia
        • 8.5.4.4.1. Market Opportunities and Trends
        • 8.5.4.4.2. Growth Prospects
      • 8.5.4.5. Others
        • 8.5.4.5.1. Market Opportunities and Trends
        • 8.5.4.5.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type (Cardiovascular Health)
    • 8.6.2. By Product Type (Bone Health)
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. Australia
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. South Korea
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Now Health Group Inc.
  • 10.2. Herbal Hills
  • 10.3. Nature's Way Products, LLC
  • 10.4. Cosmic Nutracos Solutions Private Limited
  • 10.5. Nestle Health Science S.A.
  • 10.6. Nordic Naturals
  • 10.7. Abbott Laboratories
  • 10.8. Ion Labs
  • 10.9. Amway
  • 10.10. GNC Holdings Inc.